Impact of Diabetes and Smoking on Mortality in Tuberculosis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Reed, George W ^a   Choi, Hongjo ^b   Lee, So Young ^b   Lee, Myungsun ^b   Kim, Youngran ^b   Park, Hyemi ^b   Lee, Jongseok ^b   Zhan, Xin ^a   Kang, Hyeungseok ^d   Hwang, SooHee ^d   Carroll, Matthew ^e   Cai, Ying ^e   Cho, Sang Nae ^b,c   Barry III, Clifton E ^e   Via, Laura E ^e   Kornfeld, Hardy ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b International Tuberculosis Research Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d National Masan Tuberculosis Hospital   (South Korea)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; LONGITUDINAL STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; RECURRENT INFECTION; RELAPSE; RETREATMENT; SMOKING; SOUTH KOREA; SURVIVAL RATE; THORAX RADIOGRAPHY;

AGED; ANTITUBERCULAR AGENTS; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; SMOKING; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84874561615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058044     Document Type: Article

References (25)

1. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375: 1814-1829.
2. Getahun H, Gunneberg C, Granich R, Nunn P, (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50Suppl 3: S201-S207.
3. Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 135: 483-491.
4. Jee SH, Golub JE, Jo J, Park IS, Ohrr H, et al. (2009) Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 170: 1478-1485.
5. Jeon CY, Murray MB, (2008) Diabetes mellitus increases the risk of active tuberculosis: a systemic review of 13 observational studies. PLoS Med 5: e152.
6. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9: 81.
7. Yim JJ, Selvaraj P, (2010) Genetic susceptibility in tuberculosis. Respirology 15: 241-256.
8. Lee JW, Brancati FL, Yeh HC, (2011) Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 34: 353-357.
9. Shamputa IC, Lee J, Allix-Beguec C, Cho EJ, Lee JI, et al. (2010) Genetic diversity of Mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in South Korea. J Clin Microbiol 48: 387-394.
10. Long ED, Hopkins FD, (1952) History of diagnostic standards and classification of tuberculosis of the National Tuberculosis Association. Am Rev Tuberc 65: 494-504.
11. Cleveland WS (1993) Bivariate Data. In: Visualizing Data. Summit, NJ: Hobart Press. 86-179.
12. Wang JY, Lee LN, Lai HC, Hsu HL, Liaw YS, Hsueh PR, Yang PC, (2007) Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis 196: 281-288.
13. World Health Organization (2011) Global Tuberculosis Control: WHO report 2011. Geneva, Switzerland: World Health Organization. Publication no. WHO/HTM/TB/2011.16.
14. Choi YJ, Kim HC, Kim HM, Park SW, Kim J, et al. (2009) Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care 32: 2016-2020.
15. Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW, et al. (2002) A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis 6: 1114-1117.
16. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, et al. (2002) Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 34: 752-759.
17. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W, (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80: 634-639.
18. Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, et al. (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 137: 203-210.
19. Wang CS, Chen HC, Yang CJ, Wang WY, Chong IW, et al. (2008) The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 36: 335-340.
20. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37: 518-524.
21. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634-641.
22. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167: 1486-1494.
23. Park SW, Shin JW, Kim JY, Park IW, Choi BW, et al. (2012) The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 31: 1305-1310.
24. Baker MA, Lin H-H, Chang H-Y, Murray MB, (2012) The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Clin Infect Dis 53: 818-825.
25. Menzies D, Al JH, Al OB, (2011) Recent developments in treatment of latent tuberculosis infection. Indian J Med Res 133: 257-266.